Thank you for your confirmation!

We look forward to your attendance to the event.

Latest news

Allegria Therapeutics raises 3.5 million dollars in seed financing round

Allegria Therapeutics has received seed funding of 3.5 million dollars from the founding investor Forty51 Ventures. The Basel-based biotech startup...
Read More

BioVersys extends Series C financing round to 44.9 million Swiss francs

Basel-based BioVersys is bolstering its partnership with GSK in order to accelerate the development of alpibectir for the treatment of...
Read More
1 2 3 235

No event found!